
    
      Prospective Open-label Interventional Study Randomized, self-controlled design in which one
      eye (Group A) receives Dextenza and the second eye (Group B) receives prednisolone acetate 1%
      QID 1 week, BID 1 week following bilateral PRK surgery. All eyes will receive topical
      moxifloxacin QID for one week. Moxifloxacin in used post-op regardless of the research.
      Post-operative evaluations to be performed on Day 3 and Day 4, Month 1, and Month 3. Phone
      call survey to be performed on Week 2.
    
  